FDA — authorised 24 April 1975
- Application: NDA009436
- Marketing authorisation holder: NOVARTIS
- Local brand name: ACYLANID
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Acylanid in United States
FDA authorised Acylanid on 24 April 1975
Marketing authorisations
FDA
- Status: approved
Acylanid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Acylanid approved in United States?
Yes. FDA authorised it on 24 April 1975; FDA has authorised it.
Who is the marketing authorisation holder for Acylanid in United States?
NOVARTIS holds the US marketing authorisation.